lobbying_activities: 1991512
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1991512 | cade23e2-6ce0-4b5e-a2a5-31b8a08e9d47 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2017 | second_quarter | MED | AACC met with House and Senate members and staff to express concerns about legislative efforts to extend Food and Drug Administration oversight to laboratory developed tests, which are currently regulated by the Centers for Medicare and Medicaid Services under CLIA'88. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-07-18T12:49:03.083000-04:00 |